-
Edward J. Benz, Jr., MD
President and Chief Executive Officer
Edward J. Benz, Jr., MD, became the president and chief
executive officer of the Institute in 2000 and also serves as
chief executive officer of Dana-Farber/Partners CancerCare,
director of Dana-Farber/Harvard Cancer Center, and as a trustee of
Dana-Farber/Children's Hospital Cancer Care. Dr. Benz is
presently the Richard and Susan Smith Professor of Medicine,
professor of Pediatrics, professor of Pathology, and faculty dean
for Oncology at Harvard Medical School. He received a
bachelor's degree, cum laude, from
Princeton University, a medical degree, magna
cum laude, from Harvard Medical School, and a master's
degree (privatum) from Yale
University. Immediately prior to assuming the presidency of the
Institute, Dr. Benz was chairman of the Department of Medicine at
the Johns Hopkins University School of Medicine and the Sir
William Osler Professor of Medicine. Author of over 200 articles,
books, chapters, reviews, and abstracts, he is a past president of
both the American Society of Hematology and the American Society
of Clinical Investigation, and is currently an associate editor of
the New England Journal of
Medicine.
-
Janet E. Porter, PhD
Executive Vice President and Chief Operating Officer
Janet E. Porter, PhD, joined Dana-Farber as its executive vice president and chief operating officer in January 2006. In this role, she oversees the daily operations of Dana-Farber and works closely with its collaborating hospitals to help manage administration of the Dana-Farber/Brigham and Women's Cancer Center and Dana-Farber/Children's Hospital Cancer Care and she serves on the leadership team of Dana-Farber/Partners CancerCare. Prior to joining Dana-Farber, Dr. Porter served for nine years as the chief operating officer of Children's Hospital and as the executive director of the Children's Hospital Research Foundation in Columbus, Ohio. Most recently, she was the associate dean for executive education at the University of North Carolina's School of Public Health, where she is currently an adjunct professor. Dr. Porter received her bachelor's and master's of health administration degrees from Ohio State University and her MBA and doctorate in healthcare strategy degrees from University of Minnesota.
-
Dorothy E. Puhy
Executive Vice President, Chief Financial Officer and Assistant
Treasurer
Dorothy E. Puhy became the Institute's chief financial
officer and director for Fiscal Services in March 1994. She was
named senior vice president in 2001 and executive vice president
in 2004. Ms. Puhy is chief administrative officer of
Dana-Farber/Partners CancerCare and treasurer of HealthCare
Dimensions, Inc. Prior to joining Dana-Farber, she was chief
financial officer at New England Medical Center in Boston and a
senior manager at Ernst and Whinney. Ms. Puhy received her
bachelor's degree from the University of Pennsylvania and her
business degree from the Wharton School.
-
Karen Bird
Senior Vice President for Finance
Karen Bird joined Dana-Farber in 1999 and became senior vice president for Finance in 2007. Prior to coming to Dana-Farber, Ms. Bird held positions at Faulkner Hospital, where she served as vice president for Network Development, and at New England Medical Center, where she was vice president of Finance. She received a bachelor's degree from Trinity College and a graduate degree from the Harvard School of Public Health.
-
Richard S. Boskey
Senior Vice President and General Counsel
Richard S. Boskey joined the Institute in 1999. He serves as
assistant secretary of Dana-Farber Cancer Institute and
Dana-Farber/Partners CancerCare, and secretary of the Dana-Farber
Trust, Inc. and Dana-Farber/Children's Hospital Cancer
Care. Previously, he served in various positions at Partners
HealthCare and Massachusetts General Hospital, including deputy
general counsel, and was an associate at the law firm Hill &
Barlow. Mr. Boskey received his bachelor's degree from Brown
University and his master's and law degrees from the
University of Virginia.
-
Beverly R. Ginsburg-Cooper, MBA
Senior Vice President for Research
Beverly R. Ginsburg-Cooper came to Dana-Farber in November 2006 from the University of Pennsylvania, where she served for 16 years as executive director of the Abramson Cancer Center. Prior to that, Ms. Ginsburg-Cooper was president of Medical Partnerships, Inc., vice president of Pennsylvania Hospital, and chief operating officer of a community hospital. Ms. Ginsburg-Cooper received her bachelor's degree in education from Adelphi University and her MBA from the Wharton School of the University of Pennsylvania. Currently, she is president of the Cancer Center Administrators Forum and a member of the external advisory boards of several comprehensive cancer centers.
-
James D. Griffin, MD
Chair, Department of Medical Oncology
James D. Griffin, MD, received his medical degree from Harvard
Medical School in 1974. After residency training in internal
medicine at Johns Hopkins Hospital, he completed a hematology
fellowship at Massachusetts General Hospital and a medical
oncology fellowship at Dana-Farber. In 1981, he joined the staff
of Dana-Farber, where he currently is director of the Leukemia
Program and chair of the Department of Medical Oncology. From 1993
to 1998, he was editor-in-chief of Blood. He is a professor of Medicine at
Harvard Medical School and currently sits on the scientific
advisory boards of the Lombardi Cancer Center at Georgetown
University and the Johns Hopkins Cancer Center and Case Western
Cancer Center.
-
Jay R. Harris, MD
Chair, Department of Radiation Oncology
Jay R. Harris, MD, received his medical degree from Stanford
University in 1970. He trained in radiation oncology at the
Harvard Joint Center for Radiation Therapy, and joined the
Dana-Farber staff in 1977. Dr. Harris chairs the Department of
Radiation Oncology at Dana-Farber, Brigham and Women's
Hospital, and Children's Hospital Boston, which constitute the
Longwood Radiation Oncology Center. He is also a professor of
Radiation Oncology at Harvard Medical School.
-
Philip Kantoff, MD
Chief Clinical Research Officer
Philip Kantoff, MD, graduated from Brown University Medical School in 1979. After completing his internship, residency and chief residency in internal medicine at New York University Hospital and Bellevue Hospital, he spent four years at the National Institutes of Health conducting research in gene therapy. He joined Dana-Farber in 1987 and became director of what is now the Lank Center for Genitourinary Oncology in 1988. Dr. Kantoff is chief of the Division of Solid Tumor Oncology, leader of the Dana-Farber/Harvard Cancer Center Prostate Cancer Program, and director of the Prostate Cancer Specialized Program of Research Excellence (SPORE). He is also a professor of Medicine at Harvard Medical School. He became chief clinical research officer in October 2006.
-
Darlene Lewis, PhD
Senior Vice President for Human Resources
Darlene Lewis came to Dana-Farber in 2007 from the University of Chicago Medical Center, where she served as vice president and chief human resources officer in charge of overseeing employee relations functions for the organization's 9,300 staff members. She earned a PhD in Organizational Development from Benedictine University in 2007, and holds a master's degree from the University of Illinois, Urbana-Champaign, and a bachelor's degree from San Diego State University. Ms. Lewis is active in a wide range of community and professional organizations.
-
Lee M. Nadler, MD
Senior Vice President, Experimental Medicine
Lee M. Nadler, MD, received his medical degree from Harvard
Medical School in 1973. After residency training at
Columbia-Presbyterian Medical Center, and training at the National
Cancer Institute in tumor immunology, he completed a medical
oncology fellowship at Dana-Farber, where he joined the staff in
1980. During his tenure at Dana-Farber, he has served as chief of
the Division of Hematologic Malignancies and was the first chair
of the Department of Adult Oncology. Dr. Nadler is the Virginia
and D.K. Ludwig Professor of Medicine at Harvard Medical School
and the Pan Mass Challenge Senior Investigator at Dana-Farber.
-
Stuart H. Orkin, MD
Chairman, Department of Pediatric Oncology
Stuart H. Orkin, MD, received his medical degree in 1972 from
Harvard Medical School, followed by postdoctoral research at the
National Institutes of Health and clinical training in pediatrics
and hematology-oncology at Children's Hospital Boston and
Dana-Farber, where he joined the faculty in 1978. Dr. Orkin is a
Howard Hughes Medical Institute Investigator and the David
G. Nathan Professor of Pediatrics at Harvard Medical School. Over
the past decade, his laboratory has defined critical nuclear
regulators of hematopoiesis.
-
Susan S. Paresky
Senior Vice President for Development
Susan S. Paresky joined the Institute in 1997. She was
associate dean for Development at the Harvard School of Public
Health, where she executed the school's fundraising program as
part of Harvard University's $2 billion campaign. She has also
held senior positions at Brandeis University and Wheaton
College. Ms. Paresky received her business degree from Simmons
Graduate School of Management and her bachelor's degree from
Wheaton College, where she now serves as a trustee.
-
Patricia Reid Ponte, RN, DNSc, FAAN
Senior Vice President for Patient Care Services and Chief of Nursing
Patricia Reid Ponte, RN, DNSc, FAAN, also serves as the nursing
director of the Hematology/Oncology, Bone Marrow Transplant
Program at Brigham and Women's Hospital and as the cancer
center nurse leader for Dana-Farber/Partners CancerCare. She
received her bachelor's degree in nursing from the University
of Massachusetts, Amherst, and her master's and doctorate
degrees from Boston University. Dr Reid Ponte completed a three
year Robert Wood Johnson Nurse Executive Fellowship in 2004 and
was inducted into the American Academy of Nursing.
-
Barrett J. Rollins, MD, PhD
Chief Scientific Officer
Barrett J. Rollins, MD, PhD, received his doctoral degree in 1979 and
medical degree in 1980 from Case Western Reserve University and completed
his internship and residency in internal medicine at Beth Israel Hospital,
Boston. He then performed clinical and research fellowships in medical
oncology at Dana-Farber and joined the Institute's faculty in 1986. Dr.
Rollins is currently Professor of Medicine at Harvard Medical School.
-
Stephen E. Sallan, MD
Chief of Staff
Stephen E. Sallan, MD, joined the institute in 1973 as a
trainee before becoming a member of the staff in the Department of
Pediatric Oncology. He was named chief of staff and chairman of
the Medial Staff Executive Committee in 1995. Dr. Sallan received
his undergraduate and medical degrees from Wayne State
University. He is presently a professor of Pediatrics at Harvard
Medical School, and was named the Quick Family Senior Investigator
in 2002.
-
Lawrence N. Shulman, MD
Chief Medical Officer and Senior Vice President for Medical Affairs
Lawrence N. Shulman, MD, became chief medical officer and
senior vice president for Medical Affairs at the Institute in June
2002. Prior to that, he served as Dana-Farber's vice chair for
Clinical Services for the Department of Adult
Oncology. Dr. Shulman is involved in clinical research and care
for patients with breast cancer and lymphoma. He is an associate
professor of Medicine at Harvard Medical School, and received his
bachelor's degree from Syracuse University and his medical
degree from Harvard Medical School.
-
Steven R. Singer
Senior Vice President for Communications
Steven R. Singer joined the Institute in 1997. He previously
served as director of Communications and Public Affairs and
adjunct lecturer at Harvard University's John F. Kennedy
School of Government. He has worked as a press secretary in the
U.S. House of Representatives, and is past chair of the National Cancer
Institute's Public Affairs Network. Mr. Singer received his
bachelor's degree from Colby College and a master's degree in
public administration from the Kennedy School.
